CONTACT-01: A phase III, randomized study of atezolizumab plus cabozantinib versus docetaxel in patients with metastatic non-small cell lung cancer (mNSCLC) previously treated with PD-L1/PD-1 inhibitors and platinum-containing chemotherapy.
暂无分享,去创建一个
J. Neal | N. Pavlakis | P. Kundu | Sang-We Kim | A. Balestrini | Tomohiro Tanaka | Y. Goto | T. Newsom-Davis | Jin Wang | I. Enquist | S. Patel